Related Experiment Video
Updated: Aug 16, 2025

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Genetic and Epigenetic Alterations in Parathyroid Neoplasms
Seyed Amir Miratashi Yazdi1, Elham Nazar2
1Department of General Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Parathyroid carcinoma (PC) management is complex. Lack of parafibromin expression, a marker for HRPT2 mutations, aids diagnosis and prognosis, suggesting targeted therapies for PC.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- The precise causes of parathyroid carcinoma (PC) remain unknown.
- Established associations link PC to inherited syndromes and specific genetic mutations.
- Managing PC presents significant clinical challenges due to increasing molecular complexity with tumor aggressiveness.
Purpose of the Study:
- To highlight the diagnostic and prognostic significance of parafibromin expression and HRPT2 mutations in parathyroid carcinoma.
- To underscore the role of epigenetic alterations in parathyroid tumorigenesis.
- To propose the consideration of adjuvant genetic and epigenetic targeted therapies for PC treatment.
Main Methods:
- Immunohistochemistry staining for parafibromin.
- HRPT2 mutation analysis.
- Review of established knowledge on epigenetic alterations in parathyroid tumorigenesis.
Main Results:
- Lack of parafibromin expression on immunohistochemistry, alongside HRPT2 mutations, is crucial for differentiating parathyroid carcinoma from adenoma.
- Parafibromin deficiency is a validated diagnostic, prognostic, and predictive marker for parathyroid carcinoma.
- Epigenetic alterations, including DNA methylation and chromatin structure modifications, are implicated in parathyroid tumor development.
Conclusions:
- Parafibromin deficiency serves as a key marker in parathyroid carcinoma diagnosis and management.
- Epigenetic modifications play a significant role in the development of parathyroid tumors.
- Adjuvant genetic and epigenetic targeted therapies represent a promising avenue for treating patients with parathyroid carcinoma.
More Related Videos
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
07:12Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
Related Concept Videos
Epigenetic Regulation
X-chromosome...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...